 |
|
|
| |
ITPA Deficiency is Associated with Lower Rates of Anemia and EPO use in Patients Treated with Boceprevir (BOC) plus Peginterferon/Ribavirin (PR)
|
| |
| |
Reported by jules Levin AASLD Nov 5-8 2011 SF
Mark S. Sulkowski MD1; K. Rajender Reddy MD2; Lisa D. Pedicone PhD3; Junwu Shen PhD3; Margaret Burroughs MD3; Clifford A. Brass MD, PhD3; Janice K. Albrecht PhD3; Michael P. Manns MD4
1Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2University of Pennsylvania, Philadelphia, PA, USA;
3Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 4Medical School of Hannover, Hannover, Germany
|
| |
|
|
|
|
|
